Methylprednisolone-induced Acute Pancreatitis, a Case Presentation

Discov Med. 2022 Sep-Oct;34(172):79-81.

Abstract

Acute pancreatitis is one of the leading gastrointestinal causes of hospitalization in the United States, with drug-induced acute pancreatitis being rare which is only about 0.1-2% of all acute pancreatitis cases (Balani and Grendell, 2008). Based on current publications, there are about 100 medications that can potentially cause drug-induced acute pancreatitis. In this article, we present a case of a 74-year-old man who had been treated with high doses of methylprednisolone for three days prior to the presentation of symptoms in accordance with those of acute pancreatitis. A detailed evaluation of the patient's medical history and exclusion of other probable etiologies confirmed the diagnosis of methylprednisolone-induced pancreatitis. The treatment is supportive care and withdrawal of the offending agent. The diagnosis of drug-induced pancreatitis remains a challenge for clinicians. This case may add further evidence for the role of methylprednisolone in drug-induced acute pancreatitis. It also serves as a reminder to look closely at the patient's history and medications when a cause for acute pancreatitis is not immediately found.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Aged
  • Humans
  • Male
  • Methylprednisolone / adverse effects
  • Pancreatitis* / chemically induced
  • Pancreatitis* / diagnosis

Substances

  • Methylprednisolone